Clinical trial
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
NCT01733810 is registered in ClinicalTrials.gov with Dallas VA Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
- Lead sponsor
- Dallas VA Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2013
- Completion date
- July 31, 2019
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophagitis, gastroesophageal reflux disease, reflux esophagitis